Exhibit 2.1
EXECUTION COPY
AGREEMENT AND PLAN OF MERGER
by and among
EXPRESS SCRIPTS, INC.,
PONY ACQUISITION CORPORATION
and
PRIORITY HEALTHCARE CORPORATION
Dated as of July 21, 2005
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
|
|
|
ARTICLE I
|
|
|
|
|
|
|
|
THE MERGER
|
|
|
|
|
|
|
|
The
Merger
|
|
|
1
|
|
|
|
|
Closing
|
|
|
2
|
|
|
|
|
Effective
Time
|
|
|
2
|
|
|
|
|
Effects of the
Merger
|
|
|
2
|
|
|
|
|
Articles of
Incorporation; By-laws
|
|
|
2
|
|
|
|
|
Directors and
Officers
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
ARTICLE II
|
|
|
|
|
|
|
|
CONVERSION OF SHARES; SHAREHOLDERS
MEETING
|
|
|
|
|
|
|
|
Conversion of
Securities
|
|
|
3
|
|
|
|
|
Treatment of
Company Stock Options and Restricted Stock.
|
|
|
3
|
|
|
|
|
Dissenting
Shares
|
|
|
4
|
|
|
|
|
Surrender of
Shares; Stock Transfer Books.
|
|
|
4
|
|
|
|
|
Withholding
Taxes
|
|
|
6
|
|
|
|
|
Further
Action
|
|
|
6
|
|
|
|
|
|
|
|
|
|
|
|
|
ARTICLE III
|
|
|
|
|
|
|
|
REPRESENTATIONS AND WARRANTIES OF
THE COMPANY
|
|
|
|
|
|
|
|
Organization;
Subsidiaries; Charter Documents.
|
|
|
6
|
|
|
|
|
Capitalization
of the Company.
|
|
|
8
|
|
|
|
|
Corporate
Authorization; Board Approval.
|
|
|
10
|
|
|
|
|
Governmental
Approvals
|
|
|
10
|
|
|
|
|
Non-Contravention
|
|
|
11
|
|
|
|
|
Company SEC
Documents
|
|
|
11
|
|
|
|
|
Financial
Statements; No Undisclosed Liabilities;
|
|
|
|
|
|
|
|
Internal and
Disclosure Controls.
|
|
|
12
|
|
|
|
|
Information in
Disclosure Documents
|
|
|
13
|
|
|
|
|
Absence of
Certain Changes
|
|
|
13
|
|
|
|
|
Insurance
|
|
|
13
|
|
|
|
|
Real Property;
Title to Assets.
|
|
|
14
|
|
|
|
|
Company
Intellectual Property
|
|
|
15
|
|
|
|
|
Litigation
|
|
|
15
|
|
|
|
|
Taxes
|
|
|
16
|
|
|
|
|
Employee
Benefit Plans
|
|
|
18
|
|
|
|
|
Compliance with
Laws; Permits.
|
|
|
20
|
|
|
|
|
Environmental
Matters
|
|
|
21
|
|
|
|
|
Company
Material Contracts
|
|
|
22
|
|
|
|
|
Finders’
Fees
|
|
|
24
|
|
|
|
|
Opinion of
Financial Advisor
|
|
|
24
|
|
|
|
|
Takeover
Statutes
|
|
|
24
|
|
|
|
|
Transactions
with Affiliates
|
|
|
24
|
|
|
|
|
Labor
Matters
|
|
|
24
|
|
-i-
|
|
|
|
|
|
|
|
|
|
|
Knowledge.
|
|
|
25
|
|
|
|
|
|
|
|
|
|
|
|
|
ARTICLE IV
|
|
|
|
|
|
|
|
REPRESENTATIONS AND WARRANTIES OF
PARENT AND SUB
|
|
|
|
|
|
|
|
Organization
and Power
|
|
|
25
|
|
|
|
|
Corporate
Authorization
|
|
|
25
|
|
|
|
|
Governmental
Authorization
|
|
|
26
|
|
|
|
|
Non-Contravention
|
|
|
26
|
|
|
|
|
Information
Supplied
|
|
|
26
|
|
|
|
|
Litigation
|
|
|
26
|
|
|
|
|
Finders’
Fees
|
|
|
27
|
|
|
|
|
Sub
|
|
|
27
|
|
|
|
|
Knowledge
|
|
|
27
|
|
|
|
|
|
|
|
|
|
|
|
|
ARTICLE V
|
|
|
|
|
|
|
|
COVENANTS
|
|
|
|
|
|
|
|
Interim
Operations of the Company
|
|
|
27
|
|
|
|
|
Access to
Information
|
|
|
30
|
|
|
|
|
Regulatory
Matters
|
|
|
30
|
|
|
|
|
Employee
Matters
|
|
|
31
|
|
|
|
|
No
Solicitation
|
|
|
32
|
|
|
|
|
Shareholders
Meeting
|
|
|
34
|
|
|
|
|
Additional
Agreements
|
|
|
35
|
|
|
|
|
Publicity
|
|
|
35
|
|
|
|
|
Notification of
Certain Matters
|
|
|
36
|
|
|
|
|
Directors’ and Officers’ Insurance
and Indemnification
|
|
|
36
|
|
|
|
|
Proxy
Statement
|
|
|
37
|
|
|
|
|
Cooperation
|
|
|
38
|
|
|
|
|
|
|
|
|
|
|
|
|
ARTICLE VI
|
|
|
|
|
|
|
|
CONDITIONS
|
|
|
|
|
|
|
|
Conditions to
the Obligations of Each Party
|
|
|
39
|
|
|
|
|
Conditions to
the Obligations of Parent and Sub
|
|
|
39
|
|
|
|
|
Conditions to
the Obligations of the Company
|
|
|
40
|
|
|
|
|
|
|
|
|
|
|
|
|
ARTICLE VII
|
|
|
|
|
|
|
|
TERMINATION
|
|
|
|
|
|
|
|
Termination
|
|
|
41
|
|
|
|
|
Notice of
Termination; Effect of Termination.
|
|
|
42
|
|
|
|
|
Expenses;
Termination Fees.
|
|
|
43
|
|
|
|
|
|
|
|
|
|
|
|
|
ARTICLE VIII
|
|
|
|
|
|
|
|
MISCELLANEOUS
|
|
|
|
|
|
|
|
Definitions
|
|
|
44
|
|
|
|
|
Amendment and
Modification
|
|
|
45
|
|
|
|
|
Nonsurvival of
Representations and Warranties
|
|
|
46
|
|
|
|
|
Notices
|
|
|
46
|
|
-ii-
|
|
|
|
|
|
|
|
|
|
|
Interpretation
|
|
|
47
|
|
|
|
|
Counterparts
|
|
|
47
|
|
|
|
|
Entire
Agreement; No Third Party Beneficiaries
|
|
|
47
|
|
|
|
|
Severability
|
|
|
47
|
|
|
|
|
Specific
Performance
|
|
|
48
|
|
|
|
|
Governing
Law
|
|
|
48
|
|
|
|
|
Assignment
|
|
|
48
|
|
|
|
|
Consent to
Jurisdiction; Waiver of Jury Trial
|
|
|
48
|
|
-iii-
AGREEMENT AND PLAN OF MERGER
AGREEMENT AND PLAN
OF MERGER (this “ Agreement ”), dated as of
July 21, 2005, by and among EXPRESS SCRIPTS, INC., a Delaware
corporation (“ Parent ”), PONY ACQUISITION
CORPORATION, an Indiana corporation and a wholly owned subsidiary
of Parent (“ Sub ”), and PRIORITY HEALTHCARE
CORPORATION, an Indiana corporation (the “ Company
”).
WHEREAS, the Board
of Directors of the Company has (i) determined that the
Merger, including the consideration to be paid for each outstanding
share (collectively, the “ Shares ”) of (A)
Class A Common Stock, par value $.01 per share, of the Company
(the “ Class A Company Common Stock ”) and
(B) Class B Common Stock, par value $.01 per share, of
the Company (the “ Class B Company Common Stock
”, and together with the Class A Common Stock, the
“ Company Common Stock ”) in the Merger is fair
to, advisable and in the best interests of the Company and its
shareholders, (ii) adopted this Agreement and the Merger and
(iii) resolved to recommend approval of this Agreement and the
Merger by such shareholders;
WHEREAS, the
Boards of Directors of Parent and Sub have approved, and deem it
advisable to enter into, the Merger Agreement;
WHEREAS, as a
condition and inducement to Parent’s and Sub’s entering
into this Agreement and incurring the obligations set forth herein,
concurrently with the execution and delivery of this Agreement,
Parent and Sub are entering into a Voting Agreement (the “
Voting Agreement ”) with William E. Bindley (“
Mr. Bindley ”) in his individual capacity and
with certain charitable remainder and grantor retained annuity
trusts (the “ Trusts ”) of which Mr. Bindley is
the sole trustee, pursuant to which, among other things, each of
Mr. Bindley and the Trusts has agreed to vote the shares of
Company Common Stock then owned by him or it in favor of the
approval of this Agreement and the Merger; and
WHEREAS, the Board
of Directors of the Company has approved in advance the
transactions contemplated by this Agreement and the Voting
Agreement for purposes of the provisions of Section 23-1-43 of the
Indiana Business Corporation Law (the “ IBCL ”)
and has amended its By-laws to provide that the provisions of
Section 23-1-42 shall not be applicable to the
Company.
NOW, THEREFORE, in
consideration of the foregoing and the respective representations,
warranties, covenants and agreements set forth herein, the parties
hereto agree as follows:
ARTICLE I
THE MERGER
Section 1.1.
The Merger . Upon the terms and subject to the conditions of
this Agreement, and in accordance with the IBCL, at the Effective
Time, Sub shall be merged with and into the Company (the “
Merger ”). As a result of the Merger, the separate
corporate
existence of Sub shall cease and
the Company shall continue as the surviving corporation of the
Merger (the “ Surviving Corporation
”).
Section 1.2.
Closing . Upon the terms and subject to the conditions set
forth in this Agreement, the closing of the Merger (the “
Closing ”) shall take place at 10:00 a.m. on a
date (the “ Closing Date ”) which shall be the
second business day after satisfaction or waiver of the conditions
set forth in Article VI, other than those conditions that by
their nature are to be satisfied at the Closing, but subject to the
fulfillment or waiver of those conditions, at the offices of
Simpson Thacher & Bartlett LLP, 425 Lexington Avenue, New York,
New York 10017 or at such other time, date or place as agreed to in
writing by the parties hereto.
Section 1.3.
Effective Time . Upon the Closing, the parties hereto shall
cause the Merger to be consummated by filing articles of merger
(the “ Articles of Merger ”) with the Secretary
of State of the State of Indiana, in such form as required by, and
executed in accordance with the relevant provisions of, the IBCL.
The date and time of the filing of the Articles of Merger with the
Secretary of State of the State of Indiana (or such later time as
shall be agreed to by the parties hereto and is specified in the
Articles of Merger) will be the “ Effective Time
”.
Section 1.4.
Effects of the Merger . The Merger shall have the effects
set forth in the applicable provisions of the IBCL. Without
limiting the generality of the foregoing, and subject thereto, at
the Effective Time all the property, rights, privileges,
immunities, powers and franchises of the Company and Sub shall vest
in the Surviving Corporation, and all debts, liabilities and duties
of the Company and Sub shall become the debts, liabilities and
duties of the Surviving Corporation.
Section 1.5.
Articles of Incorporation; By-laws . (a) At the
Effective Time and without any further action on the part of the
Company or Sub, the restated articles of incorporation of the
Company as in effect immediately prior to the Effective Time shall
be the articles of incorporation of the Surviving Corporation until
thereafter amended as provided therein and under the
IBCL.
(a) At the
Effective Time and without any further action on the part of the
Company or Sub, the by-laws of the Company, as amended, as in
effect immediately prior to the Effective Time shall be the by-laws
of the Surviving Corporation and thereafter may be amended or
repealed in accordance with their terms or the articles of
incorporation of the Surviving Corporation and as provided by
Law.
Section 1.6.
Directors and Officers . The directors of Sub immediately
prior to the Effective Time shall be the initial directors of the
Surviving Corporation, each to hold office in accordance with the
articles of incorporation and by-laws of the Surviving Corporation,
and the officers of the Company immediately prior to the Effective
Time shall be the initial officers of the Surviving Corporation, in
each case until their respective successors are duly elected or
appointed (as the case may be) and qualified.
-2-
ARTICLE II
CONVERSION OF SHARES; SHAREHOLDERS
MEETING
Section 2.1.
Conversion of Securities . At the Effective Time, by virtue
of the Merger and without any action on the part of Sub, the
Company or the holders of any of the following
securities:
(a) Each
Share issued and outstanding immediately prior to the Effective
Time (other than any Shares to be cancelled pursuant to
Section 2.1(b), Shares owned by Sub or any other wholly-owned
Subsidiary of Parent or of the Company which shall remain
outstanding and any Dissenting Shares) shall be cancelled,
extinguished and converted automatically into the right to receive
an amount equal to $28 per share in cash (the “ Merger
Consideration ”) payable to the holder thereof, without
interest, upon surrender of the certificate that prior to the
Merger represented such Share in the manner provided in
Section 2.4, less any required withholding taxes.
(b) Each
Share held in the treasury of the Company and each Share owned by
Parent immediately prior to the Effective Time shall be cancelled
and retired without any conversion thereof and no payment or
distribution shall be made with respect thereto.
(c) Each
share of common stock of Sub issued and outstanding immediately
prior to the Effective Time shall be converted into and become one
validly issued, fully paid and nonassessable share of Class B
Common Stock of the Surviving Corporation.
Section 2.2.
Treatment of Company Stock Options and Restricted Stock
.
(a) At the
Effective Time, each then outstanding option to purchase Shares
(collectively, a “ Company Stock Option ”),
granted pursuant to the Company’s 1997 Stock Option and
Incentive Plan, the Broad Based Stock Option Plan and the Outside
Directors Stock Plan (“ Company Stock Plans ”)
whether or not then vested or exercisable, shall be cancelled by
the Company, and each holder of a cancelled Company Stock Option
shall be entitled to receive at the Effective Time or as soon as
practicable thereafter from the Surviving Corporation (and, if
necessary, Parent shall provide funds to the Surviving Corporation
sufficient for such payments) in consideration for the cancellation
of such Company Stock Option an amount in cash equal to the product
of (i) the number of shares of Company Common Stock previously
subject to such Company Stock Option and (ii) the excess, if
any, of the Merger Consideration over the exercise price per share
of Company Common Stock previously subject to such Company Stock
Option.
(b) At the
Effective Time, each share of restricted stock (a “
Restricted Share ” and, collectively, the “
Restricted Shares ”) outstanding as of the Effective
Time and issued pursuant to the Company Stock Plans providing for
the grant of Restricted Share awards, to the extent not already
vested, shall vest and shall represent a right to receive the same
rights provided to other holders of Company Common Stock pursuant
to Section 2.1 above.
(c) Except as
provided herein or as otherwise agreed to by the parties, all stock
incentive plans and any other plan, program or arrangement
providing for the issuance or
-3-
grant of any interest in respect
of the Shares shall terminate as of the Effective Time, and the
Company shall, prior to the Effective Time, ensure that following
the Effective Time no holder of any Company Stock Option nor any
holder of a Restricted Share or any other equity-based right shall
have any right to acquire equity securities of the Company or the
Surviving Corporation (except to the extent required under any
tax-qualified retirement plan maintained by the Company or any of
its Subsidiaries prior to the Effective Time).
Section 2.3.
Dissenting Shares . Notwithstanding anything in this
Agreement to the contrary, Shares of Class A Company Common
Stock that are issued and outstanding immediately prior to the
Effective Time and which are held by shareholders who have not
voted in favor of or consented to the Merger and who shall have
delivered a written demand for appraisal of such shares of Company
Common Stock in the time and manner provided in
Section 23-1-44 of the IBCL and shall not have failed to
perfect or shall not have effectively withdrawn or lost their
rights to appraisal and payment under the IBCL (the “
Dissenting Shares ”) shall not be converted into the
right to receive the Merger Consideration, but shall be entitled to
receive the fair value of their Shares of Class A Company
Common Stock as shall be determined pursuant to
Section 23-1-44 of the IBCL; provided , however
, that if such holder shall have failed to perfect or shall have
effectively withdrawn or lost his, her or its right to appraisal
and payment under the IBCL, such holder’s Shares of
Class A Company Common Stock shall thereupon be deemed to have
been converted, at the Effective Time, into the right to receive
the Merger Consideration set forth in Section 2.1(a) of this
Agreement, without any interest thereon, less any required
withholding taxes. The Company shall give Parent (a) prompt
notice of any demands for appraisal pursuant to
Section 23-1-44 of the IBCL received by the Company,
withdrawals of such demands, and any other instruments served
pursuant to the IBCL and received by the Company and (b) the
opportunity to direct all negotiations and proceedings with respect
to demands for appraisal under the IBCL. The Company shall not,
except with the prior written consent of Parent, make any payment
with respect to any such demands for appraisal or offer to settle
or settle any such demands.
Section 2.4.
Surrender of Shares; Stock Transfer Books. (a) Prior to
the Effective Time, Sub shall designate a bank or trust company
(which shall be reasonably satisfactory to the Company) to act as
agent for the holders of Shares in connection with the Merger (the
“ Paying Agent ”) to receive the Merger
Consideration to which holders of Shares shall become entitled
pursuant to Section 2.1(a). When and as needed, Parent or Sub
will make, or will cause to be made, available to the Paying Agent
sufficient funds to make all payments pursuant to
Section 2.4(b). Such funds shall be invested by the Paying
Agent as directed by Sub or, after the Effective Time, the
Surviving Corporation, provided that such investments shall be in
obligations of or guaranteed by the United States of America, in
commercial paper obligations rated A-1 or P-1 or better by
Moody’s Investors Service, Inc. or Standard &
Poor’s Rating Services, respectively, or in deposit accounts,
certificates of deposit, bank repurchase or reverse repurchase
agreements or banker’s acceptances of, or Eurodollar time
deposits purchased from, commercial banks with capital exceeding
$250 million (based on the most recent financial statements of
such bank which are then publicly available at the United States
Securities and Exchange Commission (“ SEC ”) or
otherwise). Any net profit resulting from, or interest or income
produced by, such investments will be payable to the Surviving
Corporation or Parent, as Parent directs.
-4-
(b) As soon
as practicable after the Effective Time (but in no event more than
five business days after the Effective Time), the Surviving
Corporation shall cause to be mailed to each record holder, as of
the Effective Time, of an outstanding certificate or certificates
which immediately prior to the Effective Time represented Shares
(the “ Certificates ”), a letter of transmittal
(which shall specify that delivery shall be effected, and risk of
loss and title to the Certificates shall pass, only upon proper
delivery of the Certificates to the Paying Agent, and shall be in
such form and have such other provisions not inconsistent with this
Agreement as Parent and the Surviving Corporation shall reasonably
specify) and instructions for use in effecting the surrender of the
Certificates for payment of the Merger Consideration therefor. Upon
surrender to the Paying Agent of a Certificate, together with such
letter of transmittal, duly completed and validly executed in
accordance with the instructions thereto, and such other documents
as may be required pursuant to such instructions, the holder of
such Certificate shall be entitled to receive in exchange therefor
the Merger Consideration for each Share formerly represented by
such Certificate, and such Certificate shall then be cancelled.
Until so surrendered, each Certificate will represent, from and
after the Effective Time, only the right to receive the Merger
Consideration in cash as contemplated by this Article II. No
interest shall be paid or accrued for the benefit of holders of the
Certificates on the Merger Consideration payable upon the surrender
of the Certificates. If payment of the Merger Consideration is to
be made to a Person other than the Person in whose name the
surrendered Certificate is registered, it shall be a condition of
payment that the Certificate so surrendered shall be properly
endorsed or shall be otherwise in proper form for transfer and that
the Person requesting such payment shall have paid any transfer and
other taxes required by reason of the payment of the Merger
Consideration to a Person other than the registered holder of the
Certificate surrendered or shall have established to the
satisfaction of the Surviving Corporation that such tax either has
been paid or is not applicable. As used in this Agreement, “
Person ” means an individual, corporation, limited
liability company, partnership, association, trust, unincorporated
organization, other entity or group (as defined in the Exchange
Act).
(c) In the
event any Certificates shall have been lost, stolen or destroyed,
the Paying Agent shall deliver in exchange for such lost, stolen or
destroyed Certificates, upon the making of an affidavit of that
fact by the holder thereof, the Merger Consideration to which the
holder thereof is entitled pursuant to this Article II;
provided , however , that Parent or the Surviving
Corporation may, as a condition precedent to such delivery, require
the owner of such lost, stolen or destroyed Certificates to deliver
a bond in such sum as they may reasonably direct as indemnity
against any claim that may be made against Parent, the Surviving
Corporation, the Company or the Paying Agent with respect to the
Certificates alleged to have been lost, stolen or
destroyed.
(d) At any
time following six months after the Effective Time, the Surviving
Corporation shall be entitled to require the Paying Agent to
deliver to it any funds (including any interest and other income
received with respect thereto) which had been made available to the
Paying Agent and which have not been disbursed to holders of
Certificates, and thereafter such holders shall be entitled to look
to the Surviving Corporation (subject to abandoned property,
escheat or other similar Laws) only as general creditors thereof
with respect to the Merger Consideration payable, without interest,
to which such holders may be entitled pursuant to this
Article II. Notwithstanding the foregoing, none of the
Surviving Corporation, the Paying Agent
-5-
or any party hereto shall be
liable to any Person in respect of any Merger Consideration
delivered to a public official pursuant to any applicable abandoned
property, escheat or similar Law.
(e) At the
close of business on the day of the Effective Time, the stock
transfer books of the Company shall be closed and thereafter there
shall be no further registration of transfers of shares of Company
Common Stock on the records of the Company. From and after the
Effective Time, the holders of Certificates evidencing ownership of
Shares outstanding immediately prior to the Effective Time shall
cease to have any rights with respect to such Shares except as
otherwise provided for herein or by applicable Law.
Section 2.5.
Withholding Taxes . Each of the Paying Agent, the Company,
Parent and the Surviving Corporation shall be entitled to deduct
and withhold from the Merger Consideration or Merger Consideration
otherwise payable to a holder of Company Common Stock, Company
Stock Options or Restricted Shares, as the case may be, pursuant to
the Merger such amounts as the Paying Agent, the Company, Parent or
the Surviving Corporation is required to deduct and withhold with
respect to the making of such payment under the Internal Revenue
Code of 1986, as amended (the “ Code ”), or
under any applicable provision of state, local or foreign Law. To
the extent that amounts are so withheld, such amounts shall be
treated for all purposes of this Agreement as having been paid to
the holder of the Company Common Stock, Company Stock Options or
Restricted Shares, as the case may be, in respect of which such
deduction and withholding was made by the Paying Agent, the
Company, Parent or the Surviving Corporation,
respectively.
Section 2.6.
Further Action . At and after the Effective Time, the
officers and directors of Parent and the Surviving Corporation will
be authorized to execute and deliver, in the name and on behalf of
the Company and Sub, any deeds, bills of sale, assignments or
assurances and to take and do, in the name and on behalf of the
Company and Sub, any other actions and things to vest, perfect or
confirm of record or otherwise in the Surviving Corporation any and
all right, title and interest in, to and under any of the rights,
properties or assets acquired or to be acquired by the Surviving
Corporation as a result of, or in connection with, the
Merger.
ARTICLE III
REPRESENTATIONS AND WARRANTIES OF THE
COMPANY
The
Company hereby represents and warrants to Parent and Sub as
follows:
Section 3.1.
Organization; Subsidiaries; Charter Documents .
(a)
Organization . Each of the Company and its Significant
Subsidiaries is a corporation, partnership or other entity duly
organized, validly existing and in good standing (where applicable)
under the Laws of the jurisdiction of its incorporation or
organization, and has the requisite corporate or other power and
authority to own, lease and operate its properties and to carry on
its business as now being conducted. Each Subsidiary of the Company
that is not a Significant Subsidiary is a corporation, partnership
or other entity duly organized, validly existing and in good
standing under the Laws of the jurisdiction of its incorporation or
organization, and has the requisite corporate or other power and
authority to own, lease and
-6-
operate its properties and to
carry on its business as now being conducted, except where the
failure to be so duly organized, validly existing and in good
standing or to have such requisite corporate or other power and
authority has not had and would not, individually or in the
aggregate, reasonably be expected to have a Company Material
Adverse Effect. Each of the Company and its Subsidiaries is duly
qualified or licensed to do business and is in good standing in
each jurisdiction in which the property owned, leased or operated
by it or the nature of the business conducted by it makes such
qualification or licensing necessary, except where the failure to
be so duly qualified or licensed and in good standing has not had
and would not, individually or in the aggregate, reasonably be
expected to have a Company Material Adverse Effect.
As
used in this Agreement, the term “ Company Material
Adverse Effect ” means, when used with reference to one
or more events, changes, circumstances or effects, a material
adverse effect on the business, operations, assets, liabilities or
financial condition of the Company and its Subsidiaries taken as a
whole, other than events, changes, circumstances or effects that
arise out of or result from (i) economic factors generally
affecting the economy or financial markets as a whole or the
industries in which the Company or any of its Subsidiaries operates
which do not disproportionately impact the Company or any of its
Subsidiaries, (ii) any change in Laws, unless such change
adversely affects the Company or any of its Subsidiaries
disproportionately in comparison to their respective competitors,
and (iii) any event, change, circumstance or effect
attributable to the reaction of the customers, suppliers or payors
of the Company or any of its Subsidiaries to the public
announcement of the transactions contemplated by this
Agreement.
(b)
Subsidiaries . Section 3.1(b) of the Disclosure
Schedule delivered by the Company to Parent on or prior to the date
hereof (the “ Company Disclosure Schedule ”)
sets forth a complete list of the Company’s Subsidiaries and
all other entities in which the Company owns, directly or
indirectly, any shares of capital stock, equity or membership
interests and such list sets forth the jurisdiction of
organization, the authorized and outstanding capital stock and the
beneficial ownership of each Subsidiary and other entity as of the
date hereof and separately identifies each Significant
Subsidiary.
As
used in this Agreement, the term “ Subsidiary ”
means, when used with reference to any entity, any corporation or
other organization, whether incorporated or unincorporated,
(i) of which such party or any other Subsidiary of such party
is a general or managing partner or (ii) the outstanding
voting securities or interests of which, having by their terms
ordinary voting power to elect a majority of the Board of Directors
or others performing similar functions with respect to such
corporation or other organization, is directly or indirectly owned
or controlled by such entity or by any one or more of its
Subsidiaries.
As
used in this Agreement, “ Significant Subsidiary
” means a Subsidiary of a Person that would constitute a
“significant subsidiary” within the meaning of
Rule 1-02(w) of Regulation S-X of the Securities Exchange Act
of 1934, as amended (together with the rules and regulations
promulgated thereunder, the “ Exchange Act ”),
if such Rule were applicable to such Person.
-7-
(c)
Charter Documents . The Company has delivered or made
available to Parent: (i) a true and correct copy of each of
the restated articles of incorporation and by-laws of the Company,
as amended to date (collectively, the “ Company Charter
Documents ”) and (ii) true and correct copies of the
articles of incorporation and by-laws, or like organizational
documents, each as amended to date (collectively, “
Significant Subsidiary Charter Documents ”) of each of
its Significant Subsidiaries, and each such instrument is in full
force and effect. The Company is not in violation of any of the
provisions of the Company Charter Documents and each Significant
Subsidiary of the Company is not in violation of its respective
Significant Subsidiary Charter Documents.
Section 3.2.
Capitalization of the Company .
(a)
Company Capitalization . The authorized capital stock of the
Company consists of 55,000,000 shares of Class A Company
Common Stock, 180,000,000 shares of Class B Company Common
Stock and 5,000,000 shares of preferred stock, without par value,
of the Company (the “ Preferred Stock ”). As of
the close of business on July 20, 2005, (i) 6,559,293
shares of Class A Company Common Stock were issued and
outstanding, (ii) 37,493,288 shares of Class B Company
Common Stock were issued and outstanding (including 151,451
unvested Restricted Shares) and 1,344,737 shares were held by the
Company as treasury shares, (iii) 7,164,878 shares of
Class B Company Common Stock were reserved for issuance under
the Company Stock Plans (including shares referred to in
(iv) below), and 461,638 shares of Class B Common Stock
were reserved for issuance under the Company’s Employee Stock
Purchase Plan (“ Company ESPP ”),
(iv) 5,785,505 shares of Class B Company Common Stock
were reserved for issuance upon the exercise of outstanding Company
Stock Options granted under the plans and agreements applicable to
such Company Stock Options, (v) no shares of Preferred Stock were
issued and outstanding and (vi) no bonds, debentures, notes or
other instruments or evidence of indebtedness having the right to
vote (or convertible into, or exercisable or exchangeable for,
securities having the right to vote) on any matters of which
shareholders of the Company may vote were issued or outstanding.
All outstanding shares of Company Common Stock are, and all shares
which may be issued pursuant to the plans and agreements applicable
to the Company Stock Options will be, when issued in accordance
with the respective terms thereof, duly authorized, validly issued,
fully paid and non-assessable and not issued in violation of, or
are subject to, preemptive rights or similar rights. Except as set
forth above and as contemplated by this Agreement, there are no
outstanding (A) shares of capital stock or other voting
securities of the Company, (B) securities of the Company
convertible into or exchangeable or exercisable for shares of
capital stock or voting securities of the Company, (C) options,
warrants, restricted stock, restricted stock units, or other rights
to acquire from the Company, and no preemptive or similar rights,
subscriptions or other rights, convertible securities, agreements,
arrangements or commitments of any character, relating to the
capital stock or voting securities of the Company obligating the
Company to issue, register, transfer or sell, any capital stock,
voting securities or securities convertible into or exchangeable or
exercisable for capital stock or voting securities of the Company
or obligating the Company to grant, extend or enter into any such
option, warrant, restricted stock units, subscription or other
right, convertible security, agreement, arrangement or commitment
or (D) no equity equivalents, interests in the ownership or
earnings of the Company or other similar rights (the items in
clauses (A), (B), (C) and (D) being referred to
collectively as the “ Company Securities ”).
None
-8-
of the Company or its
Subsidiaries has any obligation, commitments or arrangements to
redeem, repurchase or otherwise acquire any of the Company
Securities or any of the Company Subsidiary Securities (as
hereinafter defined), including as a result of the transactions
contemplated by this Agreement or to provide funds to or make any
investment (in the form of a loan, capital contribution or
otherwise) in any Subsidiary or other Person. Except as set forth
in Section 3.2(a) of the Company Disclosure Schedule, there are no
voting trusts or registration rights or other agreements or
understandings to which the Company or any of its Subsidiaries is a
party with respect to the voting or disposition of the capital
stock of the Company or any of its Subsidiaries.
(b)
Subsidiary Capitalization . All outstanding shares of
capital stock or other interests of each Subsidiary of the Company
have been duly authorized and validly issued, are fully paid and
nonassessable and were not issued in violation of preemptive rights
or similar rights. Except as set forth in Section 3.2(b) of
the Company Disclosure Schedule, all of the outstanding shares of
capital stock of, or other ownership interests in, each Subsidiary
of the Company, is owned by the Company, directly or indirectly,
free and clear of any liens, charges, security interests, options,
claims, pledges, licenses, limitations in voting rights or other
encumbrances of any nature whatsoever (collectively, “
Liens ”). There are no outstanding (i) securities
of the Company or any of its Subsidiaries convertible into or
exchangeable or exercisable for shares of capital stock or other
voting securities or ownership interests in any Subsidiary of the
Company, or (ii) options, warrants, restricted stock,
restricted stock units or other rights to acquire from the Company
or any of its Subsidiaries, and no other obligation of the Company
or any of its Subsidiaries to issue, any capital stock, voting
securities or other ownership interests in, or any securities
convertible into or exchangeable or exercisable for, any capital
stock, voting securities or ownership interests in, any Subsidiary
of the Company or any equity equivalents, interests in the
ownership or earnings of any Subsidiary or other similar rights
(the items in clauses (i) and (ii) being referred to
collectively as the “ Company Subsidiary Securities
”).
(c)
Indebtedness . Section 3.2(c) of the Company Disclosure
Schedule sets forth a complete and correct list, as of the date of
this Agreement, of each Contract pursuant to which any Indebtedness
of the Company or its Subsidiaries is outstanding or may be
incurred in an amount in excess of $2,500,000, together with the
amount outstanding thereunder as of the date of this Agreement. No
Contract pursuant to which any Indebtedness of the Company or its
Subsidiaries is outstanding or may be incurred provides for the
right to vote (or is convertible into, or exchangeable or
exercisable for, securities having the right to vote) on any
matters on which the shareholders of the Company or its
Subsidiaries may vote.
As
used in this Agreement, the term “ Contract ”
means any agreement, contract, subcontract, lease, binding
understanding, indenture, note, option, warranty, purchase order,
license, sublicense, insurance policy, benefit plan or legally
binding commitment or undertaking of any nature, as in effect as of
the date hereof or as may hereinafter be in effect.
As
used in this Agreement, the term “ Indebtedness
” means (i) indebtedness for borrowed money, whether
secured or unsecured, (ii) obligations under conditional or
installment sale or other title retention Contracts relating to
purchased property, (iii) capitalized lease obligations and
(iv) guarantees of any of the foregoing of another
Person.
-9-
Section 3.3.
Corporate Authorization; Board Approval .
(a)
Corporate Authorization . The Company has all necessary
corporate power and authority to enter into this Agreement, to
perform its obligations hereunder and to consummate the
transactions contemplated hereby. The execution, delivery and
performance by the Company of this Agreement and the consummation
by the Company of the transactions contemplated hereby, have been
duly and validly authorized by all necessary corporate action,
except, with respect to the Merger, for the approval of this
Agreement and the Merger by a majority of all of the votes entitled
to be cast on this Agreement and the Merger by the holders of
outstanding Company Common Stock (the “ Company Requisite
Vote ”). The Company Requisite Vote is the only vote of
holders of any class or series of securities necessary to approve
this Agreement and the Merger. This Agreement has been duly
executed and delivered by the Company and, assuming the due
authorization, execution and delivery by Parent and Sub,
constitutes a valid and binding agreement of the Company,
enforceable against the Company in accordance with its terms
(subject to applicable bankruptcy, insolvency, reorganization,
moratorium, fraudulent transfer and other similar Laws affecting
creditors rights generally from time to time in effect, and to
general principles of equity good faith and fair dealing,
regardless whether in a proceeding at equity or at Law).
(b) Board
Approval . The Board of Directors of the Company has, at a
meeting duly called and held on or prior to the date hereof,
(i) determined and declared that this Agreement and the Merger
are fair to, advisable and in the best interests of the Company and
its shareholders, (ii) adopted and approved this Agreement and
the Merger, (iii) resolved to make the Company Recommendation,
(iv) directed that this Agreement and the Merger be submitted
to the Company’s shareholders for approval and
(v) approved the transactions contemplated by the Voting
Agreement for purposes of IC 23-1-43.
Section 3.4.
Governmental Approvals . The execution, delivery and
performance by the Company of this Agreement, and the consummation
by the Company of the transactions contemplated hereby, require no
action, permit, license, authorization, certification, consent,
approval, concession or franchise by or in respect of, or filing
with, any federal, state, or local U.S. or foreign government,
court, administrative agency, commission, arbitrator or other
governmental or regulatory agency or authority (a “
Governmental Authority ”) other than: (i) the
filing of the Articles of Merger with respect to the Merger with
the Secretary of State of the State of Indiana and appropriate
documents with the relevant authorities of other states in which
the Company is qualified to do business; (ii) compliance with
any applicable requirements of the Hart-Scott-Rodino Antitrust
Improvements Act of 1976, as amended (the “ HSR Act
”); (iii) such other consents, approvals, Orders,
authorizations, registrations, declarations, filings, notices and
permits set forth on Section 3.4 of the Company Disclosure
Schedule; (iv) the filing with the SEC of (A) a Proxy
Statement and other solicitation materials relating to the
Shareholders Meeting and (B) such reports under
Section 13(a), 13(d), 15(d) or 16(a) of the Exchange Act as
may be required in connection with this Agreement and the
transactions contemplated by this Agreement; and (v) such
other consents, approvals, Orders, authorizations, registrations,
declarations and filings the failure of which to be obtained or
made individually or in the aggregate would not reasonably be
expected to have a Company Material Adverse Effect.
-10-
Section 3.5.
Non-Contravention . Except as set forth in Section 3.5
of the Company Disclosure Schedule, the execution, delivery and
performance by the Company of this Agreement do not, and the
consummation of the transactions contemplated hereby will not:
(i) contravene, conflict with or violate the Company Charter
Documents, Significant Subsidiary Charter Documents or the articles
of incorporation, by-laws or like organizational documents of each
Subsidiary other than Significant Subsidiaries; (ii) subject
to obtaining the approval of this Agreement and the Merger by the
Company’s shareholders as contemplated in Section 5.6
and obtaining all the consents, approvals and authorizations
specified in clauses (i) through (v) of Section 3.4,
contravene or conflict with or constitute a violation of any
provision of any law, statute, ordinance, rule, code, or regulation
of any Governmental Authority (“ Law ”), or any
outstanding order, writ, judgment, injunction, ruling,
determination, award or decree by or with any Governmental
Authority (“ Order ”) binding upon or applicable
to the Company or its Subsidiaries or by which any of their
respective properties are bound or affected; (iii) subject to
obtaining all the consents, approvals and authorizations specified
in clauses (i) through (v) of Section 3.4 and
Section 3.5 of the Company Disclosure Schedule, constitute a
default (or an event which with notice, the lapse of time or both
would become a default) under or give rise to a right of
termination, cancellation, modification or acceleration of any
right or obligation of the Company or any of its Subsidiaries, or
cause increased liability or fees or to the loss of a material
benefit or imposition of a penalty under (A) any Contract or
(B) any Company Permit; or (iv) result in the creation or
imposition of any Liens on any asset of the Company or any of its
Subsidiaries, other than, in the case of clauses (ii),
(iii) or (iv), any such contraventions, conflicts, violations,
defaults, rights of termination, cancellation, modification,
acceleration or other occurrences or Liens that individually or in
the aggregate have not had and would not reasonably be expected to
have a Company Material Adverse Effect.
Section 3.6.
Company SEC Documents . The Company has filed all
registration statements, prospectuses, reports, schedules, forms,
statements and other documents (including exhibits and all other
information incorporated by reference) required to be filed by it
with the SEC since January 1, 2002 (collectively, the “
Company SEC Documents ”). The Company SEC Documents
(i) were prepared in accordance and complied in all material
respects with the requirements of the Securities Act of 1933, as
amended (together with the rules and regulations promulgated
thereunder, the “ Securities Act ”), or the
Exchange Act, as the case may be, applicable to the Company SEC
Documents each as in effect on the date so filed, and (ii) did
not at the time they were filed contain any untrue statement of a
material fact or omit to state a material fact required to be
stated therein or necessary in order to make the statements
therein, in the light of the circumstances under which they were
made, not misleading, except to the extent corrected by a
subsequently filed Company SEC Document filed and publicly
available prior to the date of this Agreement (including any
financial statements or other documentation incorporated by
reference therein). As of the date of this Agreement, there are no
outstanding or unresolved comments in comment letters received from
the SEC staff with respect to any of the Company SEC Documents. No
Subsidiary of the Company is required to file any form, report or
other document with the SEC.
-11-
Section 3.7.
Financial Statements; No Undisclosed Liabilities; Internal and
Disclosure Controls .
(a) Each of
the consolidated financial statements (including, in each case, any
related notes thereto) contained in the Company SEC Documents as of
their respective dates (the “ Company Financials
”): (i) complied as to form in all material respects
with all applicable accounting requirements and with the published
rules and regulations of the SEC with respect thereto, (ii) were
prepared in accordance with United States generally accepted
accounting principles (“ GAAP ”) applied on a
consistent basis throughout the periods involved (except as may be
indicated in the notes thereto or, in the case of unaudited interim
financial statements, as may be permitted by the SEC on Forms 10-Q,
8-K or any successor forms under the Exchange Act), and (iii)
fairly presented in all material respects the consolidated
financial condition of the Company and its consolidated
Subsidiaries as at the respective dates thereof and the
consolidated results of the Company’s operations and cash
flows for the periods indicated. All of the Subsidiaries of the
Company are consolidated for accounting purposes. The consolidated
balance sheet of the Company contained in the Company SEC Documents
as of January 1, 2005 is hereinafter referred to herein as the
“ Company Balance Sheet ,” and January 1,
2005 is hereinafter referred to herein as the “ Company
Balance Sheet Date ”.
(b) Except as
set forth in Section 3.7(b) of the Company Disclosure
Schedule, neither the Company nor any of its Subsidiaries has any
liabilities or obligations of any nature (whether accrued,
absolute, contingent or otherwise) except (i) liabilities or
obligations disclosed or provided for in the Company Balance Sheet
or the notes thereto or in the Company SEC Documents filed prior to
the date hereof and publicly available after the filing of the
Company SEC Document containing the Company Balance Sheet and
(ii) liabilities or obligations incurred in the ordinary
course of business or otherwise that individually or in the
aggregate have not had and would not reasonably be expected to have
a Company Material Adverse Effect.
(c) The
Company has made available to Parent a complete and correct copy of
any amendments or modifications which have not yet been filed with
the SEC to Contracts which previously had been filed by the Company
with the SEC pursuant to the Securities Act or the Exchange
Act.
(d) The
management of the Company has (i) implemented and maintains
disclosure controls and procedures (as defined in
Rule 13a-15(e) of the Exchange Act) designed to ensure that
material information relating to the Company, including its
consolidated Subsidiaries, is made known to the management of the
Company by others within those entities, and (ii) has
disclosed, based on its most recent evaluation, to the
Company’s outside auditors and the audit committee of the
Board of Directors of the Company (A) all significant
deficiencies and material weaknesses in the design or operation of
internal control over financial reporting (as defined in
Rule 13a-15(f) of the Exchange Act) which are reasonably
likely to adversely affect the Company’s ability to record,
process, summarize and report financial data and (B) any
fraud, whether or not material, that involves management or other
employees who have a significant role in the Company’s
internal control over financial reporting.
(e) Since the
enactment of the Sarbanes-Oxley Act of 2002, the Company has been
and is in compliance in all material respects with (i) the
applicable provisions of the
-12-
Sarbanes-Oxley Act of 2002 and
(ii) the applicable listing and corporate governance rules and
regulations of Nasdaq.
(f) As of the
date hereof, the Company has not identified any material weaknesses
in the design or operation of internal control over financial
reporting other than as disclosed in Section 3.7(f) of the Company
Disclosure Schedule. To the knowledge of the Company, there is no
reason to believe that its auditors and its chief executive officer
and chief financial officer will not be able to give the
certifications and attestations required pursuant to the rules and
regulations adopted pursuant to Section 404 of the
Sarbanes-Oxley Act of 2002 when next due. For purposes of this
Agreement, “knowledge of the Company”,
“Company’s knowledge” or similar
“knowledge” qualifiers mean the actual knowledge of the
executive officers of the Company for purposes of Section 16
of the Exchange Act.
Section 3.8.
Information in Disclosure Documents . Neither the Proxy
Statement to be filed with the SEC in connection with the Merger
nor any amendment or supplement to the Proxy Statement, will
contain at the date the Proxy Statement or any such amendment or
supplement is first mailed to shareholders of the Company and at
the time of the Shareholders Meeting, any untrue statement of a
material fact or omit to state any material fact required to be
stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made,
not misleading, except that no representation or warranty is made
by the Company with respect to statements made or incorporated by
reference therein based on information supplied by Parent or Sub
for inclusion or incorporation by reference in the Proxy Statement.
The Proxy Statement will, when filed with the SEC, comply as to
form in all material respects with the requirements of the Exchange
Act and the rules and regulations promulgated
thereunder.
Section 3.9.
Absence of Certain Changes . Except as disclosed in
Section 3.9 of the Company Disclosure Schedule or in the
Company SEC Documents filed and publicly available prior to the
date hereof, since the Company Balance Sheet Date, the businesses
of the Company and its Subsidiaries have been conducted in all
material respects in the ordinary course of business consistent
with past practice, and there has not been any change, development,
event, condition, occurrence or effect that individually or in the
aggregate has had or would reasonably be expected to have
(a) a Company Material Adverse Effect or (b) a material
adverse impact on the ability of the Company to consummate the
Merger. Since the Company Balance Sheet Date, except as (i)
specifically contemplated by this Agreement, (ii) disclosed in
the Company SEC Documents filed and publicly available prior to the
date of this Agreement or (iii) set forth in Section 3.9
of the Company Disclosure Schedule, there has not occurred any
action, event or failure to act that, if it had occurred after the
date of this Agreement, would have required the consent of Parent
under Section 5.1.
Section 3.10.
Insurance . Copies of all material insurance policies
applicable to the Company and its Subsidiaries have been made
available to Parent. Except as set forth in Section 3.10 of the
Company Disclosure Schedule: (i) all such policies are in full
force and effect and were in full force and effect during the
periods of time such insurance policies are purported to be in
effect; (ii) neither the Company nor any Subsidiary is in
breach or default (including any such breach or default with
respect to the payment of premiums or the giving of notice), and no
event has occurred which, with notice or the lapse of time or both,
would
-13-
constitute such a breach or
default, or permit termination or modification, under any policy;
(iii) all premiums due thereon have been paid and the Company
has not received any notice of cancellation, termination or
non-renewal of any such policy; (iv) all such insurance
polices are customary in scope and amount of coverage for the
business of the Company and its Subsidiaries; (v) all
appropriate insurers under such insurance policies have been
notified of all potentially insurable losses and pending litigation
and legal matters, and no such insurer has informed the Company or
any of its Subsidiaries of any denial of coverage or reservation of
rights thereto; and (vi) the Company and its Subsidiaries have
not received any written notice of cancellation of any material
insurance policy maintained in favor of the Company or any of its
Subsidiaries or has been denied insurance coverage, in either case,
in the past five years.
Section 3.11.
Real Property; Title to Assets .
(a) Owned
Real Property . Section 3.11(a) of the Company Disclosure
Schedule contains a true and complete list of all the real property
owned in fee by the Company and its Subsidiaries (the “
Owned Real Property ”). Each of the Company and its
Subsidiaries has good, valid, fee simple and marketable title to
each parcel of Owned Real Property, including, without limitation,
all buildings, structures, fixtures and improvements located
thereon, in each case, free and clear of all Liens, except
(i) Liens disclosed on Section 3.11(a) of the Company
Disclosure Schedule, (ii) Liens for Taxes and general and
special assessments not in default and payable without penalty and
interest or which are being contested in good faith by appropriate
proceedings, and (iii) other Liens which, individually or in
the aggregate, would not reasonably be expected to materially
interfere with the Company’s or any of its
Subsidiaries’ use and enjoyment of such Owned Real Property
or with the conduct of the business of the Company and its
Subsidiaries. Except as set forth in Section 3.11(a) of the
Disclosure Schedule, there are no outstanding Contracts for the
sale of any of the Owned Real Property. There are no leases,
subleases, licenses, concessions or any other contracts, options or
rights of first refusal or agreements granting to any Person or
entity other than the Company and its Subsidiaries any right to the
possession, use, occupancy or enjoyment of any of the Owned Real
Property or any portion thereof.
(b) Real
Property Leases . Section 3.11(b) of the Company
Disclosure Schedule contains a true and complete list of all
leases, subleases, sub-subleases, licenses and other agreements
under which the Company or any of its Subsidiaries, leases,
subleases, licenses, uses or occupies (whether as landlord, tenant,
subtenant other occupancy arrangement) or has the right to use or
occupy, now or in the future, any real property (the “
Real Property Leases ,” together with the Owned Real
Property, the “ Real Property ”). The Company
has previously furnished or otherwise made available to Parent
true, correct and complete copies of all Real Property Leases. Each
Real Property Lease constitutes the valid and legally binding
obligation of the Company or its Subsidiaries, enforceable against
the Company or its Subsidiaries, as applicable, in accordance with
its terms. With respect to each Real Property Lease (i) there
is no default or event which, with notice or lapse of time or both,
would constitute a default on the part of Company or its
Subsidiaries, or, to the knowledge of the Company any other party
thereto and (ii) except as set forth on the
Section 3.11(b) of the Company Disclosure Schedule, neither
the Company nor any of its Subsidiaries, as applicable, has
assigned, sublet or transferred its leasehold interest. Each of the
Company and its Subsidiaries has a good and valid leasehold
interest in each Real Property Lease free and clear of all Liens,
except (i) as disclosed on
-14-
Section 3.11(b) of the
Company Disclosure Schedule, (ii) Liens for Taxes and general
and special assessments not in default and payable without penalty
or interest or which are being contested in good faith by
appropriate proceedings and (iii) other liens which do not
materially interfere with the Company’s or any of its
Subsidiaries’ use and enjoyment of such Real Property Lease
or with the conduct of the business of the Company and its
Subsidiaries.
(c)
Personal Property . The Company and its Subsidiaries own or
lease all material furniture, fixtures, equipment, operating
supplies and other personal property (the “ Personal
Property ”) necessary to carry on their businesses as now
being conducted, subject to no Liens that individually or in the
aggregate have had or would reasonably be expected to have a
Company Material Adverse Effect.
Section 3.12.
Company Intellectual Property . Section 3.12 of the
Company Disclosure Schedule lists all registrations or applications
for registration of any Company Intellectual Property and all
material Company Intellectual Property. All material Company
Intellectual Property is valid, subsisting and enforceable in all
respects and the Company or its Subsidiaries own or have the right
to use all material Company Intellectual Property free and clear of
all Liens. Except as individually or in the aggregate have not had
or would not reasonably be expected to have a Company Material
Adverse Effect, (i) no Action is pending or, to the
Company’s knowledge, threatened against or affecting the
Company or any of its Subsidiaries or any of their respective
properties, which challenge the validity or use of, or the
ownership by, the Company and/or its Subsidiaries of the Company
Intellectual Property; (ii) the Company has no knowledge of
any infringement or infringing use of any of the Company
Intellectual Property or licenses by any Person; (iii) the
Company or the Subsidiaries take all reasonable actions to maintain
and protect the Company Intellectual Property, including
confidential Company Intellectual Property, and (iv) to the
Company’s knowledge, no infringement, misappropriation or
violation of any intellectual property right or other proprietary
right of any third party has occurred or will result from the
conduct of the business of the Company and its Subsidiaries or from
the signing and execution of this Agreement or the consummation of
the transactions contemplated hereby, and no claim has been made by
any third party based upon an allegation of any such
infringement.
As
used in this Agreement, the term “ Company Intellectual
Property ” means (i) all domestic and foreign
patents, trademarks, service marks, copyrights, trade names, domain
names and all material licenses running to or from the Company or
any of its Significant Subsidiaries relating to the Company’s
or any of its Significant Subsidiaries’ businesses or owned
by the Company or any of its Significant Subsidiaries,
(ii) all material common law trademarks, service marks,
copyrights and copyrightable works (including databases, software
and Internet site content), trade names, brand names and logos; and
(iii) all trade secrets, inventions, formulae, data,
improvements, know-how, confidential information, material computer
programs (including any source code and object code) documentation,
engineering and technical drawings, processes, methodologies, trade
dress, and all other proprietary technology utilized in or
incidental to the businesses of the Company and its Significant
Subsidiaries, and all common law rights relating to the
foregoing.
Section 3.13.
Litigation . (a) Except as set forth in
Section 3.13 of the Company Disclosure Schedule, there is no
action, suit, investigation, claim, charge or proceeding
-15-
(“ Actions ”)
pending against, or to the knowledge of the Company, threatened
against or affecting, the Company or any of its Subsidiaries or any
of their respective assets, properties or rights (a) by,
before or with any of the Food Drug Administration, Department of
Health and Human Services, the Drug Enforcement Administration,
state Medicaid agencies, state pharmacy boards, and other federal
and state Governmental Authorities with jurisdiction over the
dispensing or distribution of pharmaceutical products, including
controlled substances, or over the provision of health care items
or services, (b) by, before or with any other Governmental
Authority or (c) by or with any other Person, except, in the
case of clauses (b) and (c), for any such matters that
individually or in the aggregate have not had, and would not
reasonably be expected to have, a Company Material Adverse Effect.
As of the date of this Agreement, no officer or director of the
Company is a defendant in any Action commenced by shareholders of
the Company with respect to the performance of his or her duties as
an officer and/or director of the Company. Except as set forth in
Section 3.13 of the Company Disclosure Schedule, there exist
no Contracts with any of the directors and officers of the Company
or its Subsidiaries that provide for indemnification by the Company
or its Subsidiaries. Except as specifically disclosed in the
Company SEC Documents filed and publicly available prior to the
date of this Agreement, neither the Company nor any of its
Subsidiaries nor any of their respective properties or assets is or
are subject to any Order that individually or in the aggregate has
had, or would reasonably be expected to have, a Company Material
Adverse Effect.
(b) Neither
the Company nor any of its Subsidiaries has been charged with,
convicted of or pleaded nolo contendre to a crime nor, to the
knowledge of the Company, have any criminal charges been threatened
by a Governmental Authority against the Company or any of its
Subsidiaries. To the knowledge of the Company, no officer or
employee of the Company or any of its Subsidiaries has been charged
with, convicted of or pleaded nolo contendre to a crime with
respect to actions taken in the scope of his or her duties as an
officer or employee of the Company or any of its Subsidiaries nor
have any criminal charges been threatened by a Governmental
Authority against any such Person with respect to actions taken in
the scope of his or her duties as an officer or employee of the
Company or any of its Subsidiaries. Neither the Company nor any of
its Subsidiaries is subject to a governmental order or a party to a
settlement agreement or corporate integrity agreement with a
Governmental Authority that would, after the Closing, apply to any
of the businesses, properties or assets of Parent or any of its
affiliates (other than the Company or any of its Subsidiaries), nor
is any such order or agreement being threatened against the Company
or any of its Subsidiaries.
Section 3.14.
Taxes . Except as set forth on Section 3.14 of the
Company Disclosure Schedule:
(a) The
Company and each of its Subsidiaries, and each affiliated group
(within the meaning of Section 1504 of the Code) of which the
Company or any of its Subsidiaries is a member, has timely filed
(or has had timely filed on its behalf, taking into account all
applicable extensions) all material Tax Returns required by
applicable Law to be filed by it. All such Tax Returns are correct
and complete in all material respects and correctly and accurately
set forth the amount of any Taxes relating to the applicable
period. The Company and each of its Subsidiaries has timely paid
(or has had timely paid on its behalf) all Taxes due and owing
(whether or not shown on any Tax Return) and has established an
adequate reserve for the
-16-
payment of all Taxes not yet due
and owing in the Company Financials in accordance with
GAAP.
(b) The
Company and each of its Subsidiaries has withheld and paid all
Taxes required to have been withheld and paid in connection with
any amounts paid or owing to any employee, independent contractor,
creditor, shareholder, or other third party.
(c) As of the
date of this Agreement, none of the material Tax Returns of the
Company or its Subsidiaries filed during any of the most recent six
years have been examined by any Taxing Authority and no material
audit, action, proceeding or assessment is pending or threatened by
any such Taxing Authority against the Company or its Subsidiaries.
No written claim has been made during the most recent six years by
any Taxing Authority in a jurisdiction where neither the Company
nor any of its Subsidiaries files Tax Returns that it is or may be
subject to taxation by that jurisdiction.
(d) As of the
Closing Date, neither the Company nor its Subsidiaries will be a
party to, be bound by or have any obligation under any tax
allocation, tax sharing, tax indemnity or similar agreement with
respect to Taxes.
(e) There are
no material Liens for Taxes (other than Taxes not yet due and
payable or that are being contested in good faith) upon any of the
assets of the Company or any of its Subsidiaries.
(f) Neither
the Company nor any of its Subsidiaries (i) has ever been a
member of an “affiliated group” (as defined in Section
1504(a) of the Code) (other than a group the common parent of which
is the Company) or (ii) has any liability for Taxes of any
Person (other than the Company or any of its Subsidiaries) arising
from the application of Treasury Regulations Section 1.1502-6
or any analogous provision of state, local or foreign Law, or as a
transferee or successor, by contract, or otherwise.
(g) Neither
the Company nor any of its Subsidiaries has granted any waiver of
any federal, state, local or foreign statute of limitations with
respect to, or any extension of a period for the assessment of, any
Tax.
(h) Neither
the Company nor any of its Subsidiaries will be required to include
any item of income in, or exclude any deduction from, taxable
income for any taxable period (or portion thereof) ending after the
Closing Date as a result of any: (i) change in method of
accounting for a taxable period ending or prior to the Closing
Date; (ii) “closing agreement” as described in
Section 7121 of the Code (or any corresponding or similar
provision of state, local or foreign Tax Law) executed on or prior
to the Closing Date; (iii) intercompany transactions or any
excess loss account described in Treasury Regulations under
Section 1502 of the Code (or any corresponding or similar
provision of state, local or foreign Tax Law);
(iv) installment sale or open transaction disposition made on
or prior to the Closing Date; or (v) prepaid amount received
on or prior to the Closing Date.
-17-
(i) Neither
the Company nor any Company Subsidiary has distributed stock of
another entity, or had its stock distributed by another entity, in
a transaction that was purported or intended to be governed in
whole or in part by Section 355 or 361 of the Code.
(j) Neither
the Company nor any of its Subsidiaries has engaged in any
transaction that could give rise to (i) a disclosure
obligation with respect to any Person under Section 6111 of
the Code or the regulations promulgated thereunder, (ii) a
list maintenance obligation with respect to any Person under
Section 6112 of the Code or the regulations promulgated
thereunder, or (iii) a disclosure obligation as a
“reportable transaction” under Section 6011 of the
Code and the promulgated regulations thereunder.
(k) Neither
the Company nor any of its Subsidiaries is required to make any
payments in connection with transactions or events contemplated by
this Agreement or is a party to an agreement that would require it
to make any payments that would not be fully deductible by reason
of Section 162(m) of the Code.
As
used in this Agreement, the term “ Taxes ” means
any and all taxes, charges, fees, levies or other assessments,
including income, gross receipts, excise, real or Personal
Property, sales, withholding, social security, retirement,
unemployment, occupation, use, goods and services, service use,
license, value added, capital, net worth, payroll, profits,
employment, severance, stamp, occupation, premium, environmental,
custom duties, disability, registration, alternative or add-on
minimum, estimated, franchise, transfer and recording taxes, fees
and charges, and any other taxes, assessment or similar charges
imposed by any Taxing Authority and any interest or penalties or
additional amounts, if any, attributable to, or imposed upon, or
with respect to, any such taxes, charges, fees, levies or other
assessments whether or not disputed.
As
used in this Agreement, the term “ Taxing Authority
” means the Internal Revenue Service or any other taxing
authority, whether domestic or foreign, including any state,
county, local
|